ELIS Stock Analysis: Elis | PA
Specialty Business Services | PA, France | Market Cap: 5.231m EUR | 12M Return: 3.6% | FR0012435121 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 5.57M
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Elis SA is a France-based provider of flat linen, workwear, and hygiene and well-being solutions, operating across Europe (including France, Central Europe, Scandinavia, Eastern Europe, the UK, and Ireland), Latin America, and other international markets. Founded in 1883 and headquartered in Saint-Cloud, the company serves clients in the catering, accommodation, healthcare and social welfare, industrial, trade and retail, and services sectors, as well as public authorities. Its offering spans bed and table linen, personal protective equipment, beverage solutions (water coolers and coffee machines), floor protection mats, industrial wipers, pest and disinfection services, washroom hygiene, reusable cleanroom garments, and infectious waste collection and disposal.
Elis operates within the Industrials sector under the Diversified Support Services sub-industry, a grouping that includes outsourced facility and hygiene support providers. The business is built on a rental-and-laundering model in which customers pay recurring fees for garments, linens, and hygiene products that Elis reclaims, washes, and redistributes, a circular approach that ties revenue to long-term service contracts rather than one-time product sales.
- M&A pipeline accelerates revenue growth across European markets
- Energy and labor costs pressure operating margins
- Hospitality and healthcare recovery supports organic pricing and volume
| Net Income: 377.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA -0.74 > 1.0 |
| NWC/Revenue: -11.18% < 20% (prev -16.10%; Δ 4.92% < -1%) |
| CFO/TA 0.14 > 3% & CFO 1.40b > Net Income 377.7m |
| Net Debt (5.07b) to EBITDA (1.65b): 3.08 < 3 |
| Current Ratio: 0.77 > 1.5 & < 3 |
| Outstanding Shares: last quarter (240.6m) vs 12m ago -7.28% < -2% |
| Gross Margin: 46.93% > 18% (prev 45.99%; Δ 0.95% > 0.5%) |
| Asset Turnover: 51.46% > 50% (prev 50.90%; Δ 0.56% > 0%) |
| Interest Coverage Ratio: 4.43 > 6 (EBIT TTM 671.1m / Interest Expense TTM 151.5m) |
| A: -0.06 (Total Current Assets 1.88b - Total Current Liabilities 2.43b) / Total Assets 9.91b |
| B: 0.17 (Retained Earnings 1.68b / Total Assets 9.91b) |
| C: 0.07 (EBIT TTM 671.1m / Avg Total Assets 9.54b) |
| D: 0.54 (Book Value of Equity 3.47b / Total Liabilities 6.44b) |
| Altman-Z'' = 1.23 = BB |
| DSRI: 1.09 (Receivables 1.17b/1.02b, Revenue 4.91b/4.67b) |
| GMI: 0.98 (GM 45.99% / 46.93%) |
| AQI: 0.94 (AQ_t 0.48 / AQ_t-1 0.51) |
| SGI: 1.05 (Revenue 4.91b / 4.67b) |
| TATA: -0.10 (NI 377.7m - CFO 1.40b) / TA 9.91b) |
| Beneish M = -2.98 (Cap -4..+1) = A |
As of August 28, 2026, the stock is trading at EUR 23.90 with a total of 306,984 shares traded. Over the past week, the price has changed by -1.48%, over one month by -5.76%, over three months by -9.83% and over the past year by +3.60%.
Current recommended Stop Loss: 23.30 (which is 2.5% or 1.4 ATR below the current price).
Elis has no consensus analysts rating.
P/E Trailing = 15.9346
P/E Forward = 12.0048
P/S = 1.0651
P/B = 1.5057
Revenue TTM = 4.91b EUR
EBIT TTM = 671.1m EUR
EBITDA TTM = 1.65b EUR
Long Term Debt = 2.62b EUR (from longTermDebt, last fiscal year)
Short Term Debt = 1.33b EUR (from shortTermDebt, last quarter)
Debt = 5.52b EUR (from shortLongTermDebtTotal, last quarter) + Leases 703.2m
Net Debt = 5.07b EUR (calculated: Debt 5.52b - CCE 446.6m)
Enterprise Value = 10.3b EUR (5.23b + Debt 5.52b - CCE 446.6m)
Interest Coverage Ratio = 4.43 (Ebit TTM 671.1m / Interest Expense TTM 151.5m)
EV/FCF = 21.23x (Enterprise Value 10.3b / FCF TTM 485.4m)
FCF Yield = 4.71% (FCF TTM 485.4m / Enterprise Value 10.3b)
FCF Margin = 9.88% (FCF TTM 485.4m / Revenue TTM 4.91b)
Net Margin = 7.69% (Net Income TTM 377.7m / Revenue TTM 4.91b)
Gross Margin = 46.93% ((Revenue TTM 4.91b - Cost of Revenue TTM 2.61b) / Revenue TTM)
Gross Margin QoQ = 46.30% (prev 47.57%)
Tobins Q-Ratio = 1.04 (Enterprise Value 10.3b / Total Assets 9.91b)
Interest Expense / Debt = 2.74% (Interest Expense 151.5m / Debt 5.52b)
Taxrate = 25.00% (125.9m / 503.7m)
NOPAT = 503.4m (EBIT 671.1m * (1 - 25.00%))
Current Ratio = 0.77 (Total Current Assets 1.88b / Total Current Liabilities 2.43b)
Debt / Equity = 1.59 (Debt 5.52b / totalStockholderEquity, last quarter 3.47b)
Debt / EBITDA = 3.08 (Net Debt 5.07b / EBITDA 1.65b)
Debt / FCF = 10.45 (Net Debt 5.07b / FCF TTM 485.4m)
Total Stockholder Equity = 3.62b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.96% (Net Income 377.7m / Total Assets 9.91b)
RoE = 10.45% (Net Income TTM 377.7m / Total Stockholder Equity 3.62b)
RoCE = 10.77% (EBIT 671.1m / Capital Employed (Equity 3.62b + L.T.Debt 2.62b))
RoIC = 5.88% (NOPAT 503.4m / Invested Capital 8.57b)
WACC = 3.97% (E(5.23b)/V(10.8b) * Re(5.98%) + D(5.52b)/V(10.8b) * Rd(2.74%) * (1-Tc(0.25)))
Discount Rate = 5.98% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 16.10 | Cagr: 0.60%
[DCF] Terminal Value 74.57% ; FCFF base≈498.0m ; Y1≈474.5m ; Y5≈452.7m
[DCF] Fair Price = 9.55 (EV 7.12b - Net Debt 5.07b = Equity 2.05b / Shares 214.5m; r=8.35% [WACC [floored]]; 5y FCF grow -6.09% → 2.50% )
EPS Correlation: 50.73 | EPS CAGR: 31.65% | SUE: 0.0 | # QB: 0
Revenue Correlation: 99.79 | Revenue CAGR: 5.25% | SUE: N/A | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.00 | Chg30d=N/A | Revisions=N/A | Analysts=0
EPS current Year (2026-12-31): EPS=2.03 | Chg30d=+0.15% | Revisions=-7% | GrowthEPS=+9.5% | GrowthRev=+5.2%
EPS next Year (2027-12-31): EPS=2.19 | Chg30d=+0.26% | Revisions=+15% | GrowthEPS=+8.1% | GrowthRev=+4.2%
[Analyst] Revisions Ratio: +4% (up=11, down=10)